Carsgen’s allogenous CD19/CD20 Car-T therapy gives the first dose in a patient with an autoimmune disease

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.